Cited by

• Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

  Sakane T, Steinberg AD, Reeves JP, Green I. Sakane T, et al. J Clin Invest. 1979 May;63(5):954-65. doi: 10.1172/JCI109396. J Clin Invest. 1979. PMID: 312810 Free PMC article.
• Autoimmune diseases: immunopathology and etiopathogenesis.

  Theofilopoulos AN, Dixon FJ. Theofilopoulos AN, et al. Am J Pathol. 1982 Sep;108(3):319-65. Am J Pathol. 1982. PMID: 7051837 Free PMC article. Review. No abstract available.
• Establishment of monoclonal antibodies which possess the same characteristics as the naturally occurring thymocytotoxic autoantibodies (NTA).

  Tani K, Sakamoto H, Katoh K, Matsunagai K, Yamada S, Okuda K, Handwerger BS. Tani K, et al. Rheumatol Int. 1986;6(1):19-24. doi: 10.1007/BF00270660. Rheumatol Int. 1986. PMID: 3491409
• Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes.

  Theofilopoulos AN, Eisenberg RA, Bourdon M, Crowell JS Jr, Dixon FJ. Theofilopoulos AN, et al. J Exp Med. 1979 Feb 1;149(2):516-34. doi: 10.1084/jem.149.2.516. J Exp Med. 1979. PMID: 762500 Free PMC article.
• Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo.

  Zan-Bar I, Barzilay M, Moscovitch M, Slavin S. Zan-Bar I, et al. Clin Exp Immunol. 1983 Mar;51(3):558-64. Clin Exp Immunol. 1983. PMID: 6851246 Free PMC article.